BMSSC
DXCM icon

B. Metzler seel. Sohn & Co’s DexCom DXCM Stock Holding History

B. Metzler seel. Sohn & Co’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.19M Buy
47,413
+1,066
+2% +$71K 0.03% 321
2026
Q1 		$2.91M Buy
46,347
+16,293
+54% +$1.13M 0.03% 302
2025
Q4 		$1.99M Buy
30,054
+20,841
+226% +$1.35M 0.02% 406
2025
Q3 		$620K Sell
9,213
-2,388
-21% -$189K 0.01% 625
2025
Q2 		$1.01M Sell
11,601
-6,588
-36% -$516K 0.01% 540
2025
Q1 		$1.24M Buy
18,189
+4,141
+29% +$338K 0.01% 472
2024
Q4 		$1.09M Sell
14,048
-8,530
-38% -$632K 0.01% 516
2024
Q3 		$1.51M Sell
22,578
-34,180
-60% -$2.81M 0.02% 453
2024
Q2 		$6.43M Buy
56,758
+16,886
+42% +$2.13M 0.06% 142
2024
Q1 		$5.53M Buy
39,872
+18,549
+87% +$2.33M 0.06% 170
2023
Q4 		$2.65M Sell
21,323
-89,584
-81% -$9.15M 0.03% 305
2023
Q3 		$10.3M Sell
110,907
-32,332
-23% -$3.64M 0.16% 83
2023
Q2 		$18.4M Buy
143,239
+13,172
+10% +$1.59M 0.25% 58
2023
Q1 		$15.1M Buy
130,067
+6,755
+5% +$756K 0.24% 67
2022
Q4 		$14M Buy
123,312
+501
+0.4% +$55K 0.24% 72
2022
Q3 		$9.89M Sell
122,811
-7,337
-6% -$621K 0.18% 90
2022
Q2 		$9.7M Buy
130,148
+4,184
+3% +$382K 0.16% 98
2022
Q1 		$16.1M Sell
125,964
-23,584
-16% -$2.58M 0.22% 78
2021
Q4 		$20.2M Buy
149,548
+21,444
+17% +$3.08M 0.26% 68
2021
Q3 		$17.5M Sell
128,104
-11,044
-8% -$1.39M 0.25% 67
2021
Q2 		$14.9M Buy
139,148
+5,852
+4% +$562K 0.22% 74
2021
Q1 		$12M Buy
133,296
+121,576
+1,037% +$11.4M 0.2% 80
2020
Q4 		$1.07M Buy
+11,720
New +$1.05M 0.02% 385

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

B. Metzler seel. Sohn & Co's DXCM Position: Q2 2026 in Review

B. Metzler seel. Sohn & Co increased its DexCom (DXCM) stake by 2.3% in Q2 2026, buying an estimated $71K and bringing the position to 47,413 shares worth $3.19M. The position accounts for 0.03% of the portfolio, ranked #321.

B. Metzler seel. Sohn & Co first reported a position in DXCM in Q4 2020 and has held it in 23 quarters since. The position peaked at $20.2M in Q4 2021. 976 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • B. Metzler seel. Sohn & Co held 47,413 shares of DexCom worth $3.19M as of Q2 2026.
  • B. Metzler seel. Sohn & Co bought 1,066 DexCom shares in Q2 2026, an estimated $71K.
  • DexCom made up 0.03% of B. Metzler seel. Sohn & Co's portfolio in Q2 2026, its #321 holding.
  • B. Metzler seel. Sohn & Co first reported a position in DexCom in Q4 2020 and has held it in 23 quarters since.
  • B. Metzler seel. Sohn & Co's DexCom position peaked at $20.2M in Q4 2021.
  • 976 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on B. Metzler seel. Sohn & Co's 13F filing for Q2 2026, filed 11 Aug 2026.